| # | Drug | Count |
|---|---|---|
| 0 | SIPULEUCEL-T | 60 |
| 1 | ATORVASTATIN CALCIUM | 5 |
| 2 | ERGOCALCIFEROL | 5 |
| 3 | AMLODIPINE BESYLATE | 3 |
| 4 | DENOSUMAB | 3 |
| 5 | ENZALUTAMIDE | 3 |
| 6 | LEUPROLIDE ACETATE | 3 |
| 7 | MESALAMINE | 3 |
| 8 | ALEMTUZUMAB | 2 |
| 9 | ASPIRIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SIPULEUCEL-T | 60 | 0.0103 |
| 1 | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0049 |
| 2 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0011 |
| 3 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0006 |
| 4 | PLECANATIDE | 1 | 0.0005 |
| 5 | MEGESTROL ACETATE | 1 | 0.0003 |
| 6 | PEGVISOMANT | 1 | 0.0002 |
| 7 | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | 1 | 0.0002 |
| 8 | ERGOCALCIFEROL | 5 | 0.0002 |
| 9 | NAPROXEN SODIUM 220MG | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Autologous Cellular Immunotherapy [EPC] | 60 | 0.0103 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 3 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 5 | Androgen Receptor Inhibitor [EPC] | 3 | 0.0000 |
| 6 | Aminosalicylate [EPC] | 3 | 0.0000 |
| 7 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 8 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Dietary Cholesterol Absorption Inhibitor [EPC] | 2 | 0.0000 |